Markets
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
IPO
Alerts
About
Gland Pharma Ltd.
NSE: GLAND
|
BSE: 543245
|
ISIN: INE068V01023
|
Industry: Pharmaceuticals
|
Mid-range Performer
1822.2000
-39.00
(
-2.10
%)
NSE
Feb 27, 2026
15:31 PM
42.60% Gain from 52W Low
Volume:
118.0K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Gland Pharma Ltd.
29 Jan 2026, 12:00AM
1822.20
-2.10%
Result Update:Gland Pharma
Buy:
Gland Pharma Ltd.
by
Axis Direct
Target: 2170 | Upside : 19.1%
Recommendation
Axis Direct
We maintain our BUY rating on the stock.
Number of FII/FPI investors decreased from 260 to 236 in Dec 2025 qtr
More from Gland Pharma Ltd.
Recommended
Five Interesting Stocks Today - February 27, 2026
The Baseline |
27 Feb 2026
Market closes lower, dragged down by losses in the banking, auto, and FMCG stocks
Trendlyne Marketwatch |
27 Feb 2026
Gland Pharma IPO: A Chinese-owned pharmaceutical company hits the IPO market
|
12 Nov 2020